menu
    • menu

    Company profile for Viralgen

    NEW Drugs in Dev: 4
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Viralgen is a CDMO born as a joint venture between Askbio and Columbus Venture Partners, combining decades of technology and drug development experience in multiple platforms to support best-in-class service offerings to the gene therapy market. Viralgen was created in 2017 to respond to the unmet need for manufacturing of gene therapies, with the goal to help broaden access to these life-saving therapeutics and to contribu...
    Viralgen is a CDMO born as a joint venture between Askbio and Columbus Venture Partners, combining decades of technology and drug development experience in multiple platforms to support best-in-class service offerings to the gene therapy market. Viralgen was created in 2017 to respond to the unmet need for manufacturing of gene therapies, with the goal to help broaden access to these life-saving therapeutics and to contribute to the advancement of health and human welfare around the world.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ViralgenSpain_new Flag
    Country
    Country
    Spain
    Address
    Address
    Parque Científico y Tecnológico de Gipuzkoa Paseo Mikeletegi, 83 20009 San S...
    Telephone
    Telephone
    +34 943 47 77 33
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://viralgenvc.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Apertura, Viralgen Partner on TfR1 CapX for CNS Gene Therapies
    Apertura, Viralgen Partner on TfR1 CapX for CNS Gene Therapies

    17 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/apertura-gene-therapy-and-viralgen-announce-strategic-collaboration-to-manufacture-tfr1-capx-a-next-generation-capsid-for-gene-therapies-designed-to-treat-central-nervous-system-diseases-302714462.html

    PR NEWSWIRE
    17 Mar 2026
    Share Share
    Bayer Advances Gene And Cell Therapy Pipeline For Parkinson
    Bayer Advances Gene And Cell Therapy Pipeline For Parkinson

    13 Oct 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bayers-gene-and-cell-therapy-pipeline-aims-to-transform-parkinsons-oncology-rare-diseases-and-more/articleshow/124529407.cms

    ECONOMICTIMES
    13 Oct 2025
    Share Share
    Viralgen partners Trogenix to AAV gene therapy for glioblastoma
    Viralgen partners Trogenix to AAV gene therapy for glioblastoma

    06 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/viralgen-collaborates-with-trogenix-to-advance-aav-gene-therapy-for-glioblastoma-302445018.html

    PR NEWSWIRE
    06 May 2025
    Share Share
    Viralgen & Axovia Partner On Gene Therapy For Retinal Dystrophy
    Viralgen & Axovia Partner On Gene Therapy For Retinal Dystrophy

    22 Jan 2025

    // PR NEWSWIRE

    https://prnewswire.com/news-releases/viralgen-and-axovia-partner-to-manufacture-an-investigational-gene-therapy-for-retinal-dystrophy-in-bardet-biedl-syndrome-bbs-patients-302357167.html

    PR NEWSWIRE
    22 Jan 2025
    Share Share
    Viralgen Partners With Broad Institute to Advance Gene Therapy
    Viralgen Partners With Broad Institute to Advance Gene Therapy

    08 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/viralgen-partners-with-vallabhminikel-lab-and-deverman-lab-at-the-broad-institute-to-advance-gene-therapy-manufacturing-hope-for-prion-disease-302344759.html

    PR NEWSWIRE
    08 Jan 2025
    Share Share
    Visit Of Lehendakari Imanol Pradales And His Team To Our Facilities
    Visit Of Lehendakari Imanol Pradales And His Team To Our Facilities

    26 Sep 2024

    // PRESS RELEASE

    https://viralgenvc.com/news-and-events/visit-of-lehendakari-imanol-pradales-and-his-team-to-our-facilities

    PRESS RELEASE
    26 Sep 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search